• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产后即时宫内节育器放置的使用、效果和安全性:系统文献回顾。

Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: a systematic literature review.

机构信息

Bayer Healthcare, Whippany, New Jersey, USA.

Bayer Oy, Espoo, Uusimaa, Finland.

出版信息

BMJ Sex Reprod Health. 2023 Apr;49(2):e1. doi: 10.1136/bmjsrh-2022-201579. Epub 2022 Dec 9.

DOI:10.1136/bmjsrh-2022-201579
PMID:36600467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10176355/
Abstract

BACKGROUND

Intrauterine devices (IUDs) are highly effective contraception. IUDs inserted directly following delivery provide immediate birth control and may decrease unintended pregnancies, including short-interval pregnancies, thereby mitigating health risks and associated economic burden.

METHODS

This systematic literature review included published global data on the utilisation, effectiveness, and safety of postpartum intrauterine devices (PPIUDs) of any type. English language articles indexed in MEDLINE, Embase, and Cochrane from January 2010-October 2021 were included.

RESULTS

133 articles met the inclusion criteria (46% interventional studies; 54% observational; n=87 from lower-income countries; n=46 from higher-income countries). PPIUD use was low in higher-income countries (6/10 000 US deliveries in 2013-2016) and varied widely in lower-income countries (2%-46%). Across both higher- and lower-income countries, in most studies (79%), >80% of women with PPIUDs had an IUD in place by 3 months; at 6 and 12 months, 76% and 54% of included studies reported that >80% of women had an IUD in place; reason for discontinuation was infrequently reported. Pregnancies were rare (96 pregnancies across 12 191 women from 37 studies reporting data) and were generally unrelated to device failure, but rather occurred in women no longer using a PPIUD. Expulsions occurred mainly in the early outpatient period and ranged widely (within 3 months: 0-41%). Abnormal bleeding, infections, or perforations were rare.

CONCLUSIONS

PPIUDs are safe and effective. Long-term follow-up data are limited. Future research elucidating reasons underlying lack of PPIUD use is warranted.

摘要

背景

宫内节育器(IUD)是一种高效的避孕方法。分娩后立即放置 IUD 可提供即时避孕,并可能减少意外怀孕,包括短间隔怀孕,从而降低健康风险和相关的经济负担。

方法

本系统文献综述包括已发表的全球数据,涉及任何类型的产后宫内节育器(PPIUD)的使用、效果和安全性。纳入了 2010 年 1 月至 2021 年 10 月 MEDLINE、Embase 和 Cochrane 中索引的英文文章。

结果

133 篇文章符合纳入标准(46%为干预性研究;54%为观察性研究;87 篇来自低收入国家;46 篇来自高收入国家)。在高收入国家,PPIUD 的使用率较低(2013-2016 年每 10000 例美国分娩中有 6 例),而在低收入国家差异很大(2%-46%)。在高收入和低收入国家,在大多数研究中(79%),超过 80%的 PPIUD 妇女在 3 个月内有 IUD 放置;在 6 个月和 12 个月时,76%和 54%的纳入研究报告称,超过 80%的妇女有 IUD 放置;停止使用的原因很少报告。妊娠很少见(37 项研究报告数据中有 12191 名妇女发生 96 例妊娠),通常与器械故障无关,而是发生在不再使用 PPIUD 的妇女中。脱落主要发生在早期门诊期间,范围很广(3 个月内:0-41%)。异常出血、感染或穿孔很少见。

结论

PPIUD 是安全有效的。长期随访数据有限。未来的研究需要阐明缺乏 PPIUD 使用的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/10176355/a5b8df09ab31/bmjsrh-2022-201579f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/10176355/8b74960c3aa4/bmjsrh-2022-201579f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/10176355/a5b8df09ab31/bmjsrh-2022-201579f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/10176355/8b74960c3aa4/bmjsrh-2022-201579f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4738/10176355/a5b8df09ab31/bmjsrh-2022-201579f02.jpg

相似文献

1
Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: a systematic literature review.产后即时宫内节育器放置的使用、效果和安全性:系统文献回顾。
BMJ Sex Reprod Health. 2023 Apr;49(2):e1. doi: 10.1136/bmjsrh-2022-201579. Epub 2022 Dec 9.
2
Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.即刻与产后延迟放置避孕埋植剂和宫内节育器避孕效果比较。
Cochrane Database Syst Rev. 2022 Oct 27;10(10):CD011913. doi: 10.1002/14651858.CD011913.pub3.
3
Immediate postabortal insertion of intrauterine devices.流产后立即放置宫内节育器。
Cochrane Database Syst Rev. 2002(3):CD001777. doi: 10.1002/14651858.CD001777.
4
Postpartum intrauterine contraceptive device use and its associated factors in Ethiopia: systematic review and meta-analysis.埃塞俄比亚产后宫内节育器使用及其相关因素:系统评价和荟萃分析。
Reprod Health. 2021 Nov 13;18(1):225. doi: 10.1186/s12978-021-01273-x.
5
Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.激素浸渍宫内节育系统(IUSs)与其他形式的可逆性避孕方法作为预防妊娠的有效方法。
Cochrane Database Syst Rev. 2004;2004(3):CD001776. doi: 10.1002/14651858.CD001776.pub2.
6
Education for contraceptive use by women after childbirth.产后妇女避孕使用教育。
Cochrane Database Syst Rev. 2002(3):CD001863. doi: 10.1002/14651858.CD001863.
7
Hormonal contraception for women at risk of HIV infection.针对有感染艾滋病毒风险的女性的激素避孕法。
Cochrane Database Syst Rev. 2025 Jun 6;6(6):CD015701. doi: 10.1002/14651858.CD015701.pub2.
8
Immediate post-partum insertion of intrauterine devices.产后立即放置宫内节育器。
Cochrane Database Syst Rev. 2003(1):CD003036. doi: 10.1002/14651858.CD003036.
9
Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.预防或治疗宫内节育器使用相关的月经过多或疼痛的干预措施。
Cochrane Database Syst Rev. 2022 Aug 26;8(8):CD006034. doi: 10.1002/14651858.CD006034.pub3.
10
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD002126. doi: 10.1002/14651858.CD002126.pub2.

引用本文的文献

1
Clinician and policymaker perspectives on the barriers and enablers to implementing and scaling up integrated postpartum intrauterine contraceptive services within maternity care in Nepal: a qualitative study.临床医生和政策制定者对尼泊尔孕产妇保健中实施和扩大产后宫内避孕综合服务的障碍与促进因素的看法:一项定性研究
Lancet Reg Health Southeast Asia. 2025 May 14;37:100599. doi: 10.1016/j.lansea.2025.100599. eCollection 2025 Jun.
2
Follow-up of immediate postpartum intrauterine device insertion: a scoping review protocol.产后即时宫内节育器放置的随访:一项范围综述方案
BMJ Open. 2024 Dec 20;14(12):e092783. doi: 10.1136/bmjopen-2024-092783.
3

本文引用的文献

1
Clinical Outcome of Cu-T 375 PPIUCD by Novel Dedicated Inserter Technique.采用新型专用插入器技术放置铜-375宫内节育器的临床结局
J Obstet Gynaecol India. 2021 Aug;71(4):430-436. doi: 10.1007/s13224-021-01445-6. Epub 2021 Mar 15.
2
The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease.为患有心脏病的孕妇提供即时产后放置宫内节育器和植入物的效果。
Contraception. 2022 Jan;105:55-60. doi: 10.1016/j.contraception.2021.09.005. Epub 2021 Sep 14.
3
Increasing postpartum IUCD coverage through a QI initiative: a step towards reducing the unmet need of postpartum contraception.
Expanding access to postpartum contraception.
扩大产后避孕方法的可及性。
Curr Opin Obstet Gynecol. 2024 Oct 1;36(5):331-337. doi: 10.1097/GCO.0000000000000982. Epub 2024 Aug 2.
通过质量改进举措提高产后宫内节育器的覆盖率:迈向减少产后避孕未满足需求的一步。
BMJ Open Qual. 2021 Jul;10(Suppl 1). doi: 10.1136/bmjoq-2021-001346.
4
Factors associated with missing strings and expulsion after postplacental insertion of copper T380A intrauterine devices.产后放置铜T380A宫内节育器后与脱失及取出相关的因素。
Int J Gynaecol Obstet. 2022 Apr;157(1):67-75. doi: 10.1002/ijgo.13806. Epub 2021 Jul 27.
5
Postplacental Insertion of Levonorgestrel Intrauterine System Versus Copper Intrauterine Device: A Prospective Study.左炔诺孕酮宫内节育系统与铜宫内节育器胎盘后置入的前瞻性研究
J Obstet Gynaecol India. 2021 Apr;71(2):150-155. doi: 10.1007/s13224-020-01409-2. Epub 2021 Jan 20.
6
Understanding factors associated with continuation of intrauterine device use in Gujarat and Rajasthan, India: a cross-sectional household study.了解印度古吉拉特邦和拉贾斯坦邦与宫内节育器使用持续相关的因素:一项横断面家庭研究。
Sex Reprod Health Matters. 2021;29(2):1-16. doi: 10.1080/26410397.2021.1933815.
7
Initiation of Long-Acting Reversible Contraception in Hospitalized Adolescents in the United States.美国住院青少年中长效可逆避孕措施的启动。
Hosp Pediatr. 2021 Jul;11(7):764-770. doi: 10.1542/hpeds.2020-001974. Epub 2021 Jun 10.
8
Analysis of Postpartum Uptake of Long-Acting Reversible Contraceptives Before and After Implementation of Medicaid Reimbursement Policy.分析医疗补助报销政策实施前后长效可逆避孕药的产后使用情况。
Matern Child Health J. 2021 Sep;25(9):1361-1368. doi: 10.1007/s10995-021-03180-w. Epub 2021 Jun 9.
9
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
10
Risk factors for postpartum intrauterine device expulsion among women delivering at a tertiary Hospital in Uganda: a prospective cohort study.乌干达一家三级医院分娩妇女产后宫内节育器排出的危险因素:一项前瞻性队列研究
Contracept Reprod Med. 2021 Mar 2;6(1):7. doi: 10.1186/s40834-021-00153-w.